Organ-replacement developer Tengion Inc.'s initial public offering last week is more evidence the Philadelphia region has a leading position in developing cutting-edge drugs and therapies, a top industry official said Tuesday.
Philly.com Business, Philadelphia Inquirer & Daily News: Business
Wed, 04/14/2010 - 12:03am
Organ-replacement developer Tengion Inc.'s initial public offering last week is more evidence the Philadelphia region has a leading position in developing cutting-edge drugs and therapies, a top industry official said Tuesday.